MSF hopes that Indian Health Ministry will consider issuing a government use license, to encourage manufacturers to continue with phase III clinical trials of PCV13
The world already has a supersuccessful pneumococcal conjugate vaccine in Pfizer's Prevnar 13, but that isn't stopping PnuVax from pushing ahead with its own program.